HEADER SIGNALING PROTEIN,TRANSFERASE/INHIBITOR 18-SEP-23 8U8X TITLE CRYSTAL STRUCTURE OF THE RECEPTOR TYROSINE KINASE HUMAN HER2 (ERBB2) TITLE 2 YVMA MUTANT KINASE DOMAIN IN COMPLEX WITH INHIBITOR COMPOUND 27 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ERBB2; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS PROTO-ONCOGENE C-ERBB-2, TYROSINE KINASE-TYPE CELL SURFACE, SIGNALING KEYWDS 2 PROTEIN, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.WANG,T.C.MOU REVDAT 2 26-JUN-24 8U8X 1 JRNL REVDAT 1 12-JUN-24 8U8X 0 JRNL AUTH E.J.HICKEN,K.BROWN,N.C.DWULET,J.J.GAUDINO,E.P.HANSEN, JRNL AUTH 2 D.P.HARTLEY,J.P.KOWALSKI,E.R.LAIRD,N.C.LAZZARA,B.LI,T.C.MOU, JRNL AUTH 3 M.F.MUTRYN,L.OKO,S.PAJK,R.W.PIPAL,R.Z.ROSEN,R.SHELP,A.SINGH, JRNL AUTH 4 J.WANG,C.E.WISE,C.WONG,J.Y.WONG JRNL TITL DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JRNL TITL 2 HER2 WT AND HER2 YVMA . JRNL REF J.MED.CHEM. V. 67 9759 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38820338 JRNL DOI 10.1021/ACS.JMEDCHEM.4C00978 REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 36543 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 1779 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.7100 - 3.9700 1.00 2707 102 0.1435 0.1834 REMARK 3 2 3.9600 - 3.1500 1.00 2687 116 0.1443 0.1723 REMARK 3 3 3.1500 - 2.7500 1.00 2708 134 0.1780 0.2047 REMARK 3 4 2.7500 - 2.5000 1.00 2676 116 0.1690 0.2363 REMARK 3 5 2.5000 - 2.3200 1.00 2736 108 0.1706 0.1867 REMARK 3 6 2.3200 - 2.1900 1.00 2641 130 0.1798 0.2098 REMARK 3 7 2.1800 - 2.0800 1.00 2672 153 0.1754 0.2263 REMARK 3 8 2.0800 - 1.9900 1.00 2691 122 0.1641 0.2295 REMARK 3 9 1.9900 - 1.9100 1.00 2623 174 0.1784 0.2076 REMARK 3 10 1.9100 - 1.8400 1.00 2660 190 0.1777 0.1972 REMARK 3 11 1.8400 - 1.7900 1.00 2616 144 0.1758 0.2025 REMARK 3 12 1.7900 - 1.7300 1.00 2663 178 0.2142 0.2404 REMARK 3 13 1.7300 - 1.6900 1.00 2684 112 0.2571 0.3293 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.209 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2597 REMARK 3 ANGLE : 1.376 3522 REMARK 3 CHIRALITY : 0.079 384 REMARK 3 PLANARITY : 0.012 449 REMARK 3 DIHEDRAL : 17.045 1004 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8U8X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277625. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36435 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 29.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.400 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.78000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG 3350, 0.1M TRIS PH8.5, 0.5M REMARK 280 NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.49467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 54.98933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 692 REMARK 465 GLY A 693 REMARK 465 THR A 694 REMARK 465 GLU A 695 REMARK 465 LEU A 696 REMARK 465 VAL A 697 REMARK 465 GLU A 698 REMARK 465 PRO A 699 REMARK 465 LEU A 700 REMARK 465 THR A 701 REMARK 465 PRO A 702 REMARK 465 SER A 703 REMARK 465 GLY A 704 REMARK 465 ALA A 705 REMARK 465 MET A 706 REMARK 465 PRO A 707 REMARK 465 ASN A 708 REMARK 465 GLN A 709 REMARK 465 ALA A 710 REMARK 465 GLN A 711 REMARK 465 ILE A 767 REMARK 465 LEU A 768 REMARK 465 LEU A 998 REMARK 465 GLY A 999 REMARK 465 PRO A 1000 REMARK 465 ALA A 1001 REMARK 465 SER A 1002 REMARK 465 PRO A 1003 REMARK 465 LEU A 1004 REMARK 465 VAL A 1029 REMARK 465 PRO A 1030 REMARK 465 GLN A 1031 REMARK 465 GLN A 1032 REMARK 465 GLY A 1033 REMARK 465 HIS A 1034 REMARK 465 HIS A 1035 REMARK 465 HIS A 1036 REMARK 465 HIS A 1037 REMARK 465 HIS A 1038 REMARK 465 HIS A 1039 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 731 -10.93 74.18 REMARK 500 THR A 795 -120.94 -138.31 REMARK 500 ARG A 818 -118.01 37.02 REMARK 500 ARG A 848 -6.76 80.88 REMARK 500 ASP A 849 47.11 -152.45 REMARK 500 ASP A 867 73.23 64.69 REMARK 500 REMARK 500 REMARK: NULL DBREF 8U8X A 694 1033 UNP P04626 ERBB2_HUMAN 694 1029 SEQADV 8U8X MET A 692 UNP P04626 INITIATING METHIONINE SEQADV 8U8X GLY A 693 UNP P04626 CLONING ARTIFACT SEQADV 8U8X TYR A 776 UNP P04626 INSERTION SEQADV 8U8X VAL A 777 UNP P04626 INSERTION SEQADV 8U8X MET A 778 UNP P04626 INSERTION SEQADV 8U8X ALA A 779 UNP P04626 INSERTION SEQADV 8U8X HIS A 1034 UNP P04626 EXPRESSION TAG SEQADV 8U8X HIS A 1035 UNP P04626 EXPRESSION TAG SEQADV 8U8X HIS A 1036 UNP P04626 EXPRESSION TAG SEQADV 8U8X HIS A 1037 UNP P04626 EXPRESSION TAG SEQADV 8U8X HIS A 1038 UNP P04626 EXPRESSION TAG SEQADV 8U8X HIS A 1039 UNP P04626 EXPRESSION TAG SEQRES 1 A 348 MET GLY THR GLU LEU VAL GLU PRO LEU THR PRO SER GLY SEQRES 2 A 348 ALA MET PRO ASN GLN ALA GLN MET ARG ILE LEU LYS GLU SEQRES 3 A 348 THR GLU LEU ARG LYS VAL LYS VAL LEU GLY SER GLY ALA SEQRES 4 A 348 PHE GLY THR VAL TYR LYS GLY ILE TRP ILE PRO ASP GLY SEQRES 5 A 348 GLU ASN VAL LYS ILE PRO VAL ALA ILE LYS VAL LEU ARG SEQRES 6 A 348 GLU ASN THR SER PRO LYS ALA ASN LYS GLU ILE LEU ASP SEQRES 7 A 348 GLU ALA TYR VAL MET ALA TYR VAL MET ALA GLY VAL GLY SEQRES 8 A 348 SER PRO TYR VAL SER ARG LEU LEU GLY ILE CYS LEU THR SEQRES 9 A 348 SER THR VAL GLN LEU VAL THR GLN LEU MET PRO TYR GLY SEQRES 10 A 348 CYS LEU LEU ASP HIS VAL ARG GLU ASN ARG GLY ARG LEU SEQRES 11 A 348 GLY SER GLN ASP LEU LEU ASN TRP CYS MET GLN ILE ALA SEQRES 12 A 348 LYS GLY MET SER TYR LEU GLU ASP VAL ARG LEU VAL HIS SEQRES 13 A 348 ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS SER PRO SEQRES 14 A 348 ASN HIS VAL LYS ILE THR ASP PHE GLY LEU ALA ARG LEU SEQRES 15 A 348 LEU ASP ILE ASP GLU THR GLU TYR HIS ALA ASP GLY GLY SEQRES 16 A 348 LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU SEQRES 17 A 348 ARG ARG ARG PHE THR HIS GLN SER ASP VAL TRP SER TYR SEQRES 18 A 348 GLY VAL THR VAL TRP GLU LEU MET THR PHE GLY ALA LYS SEQRES 19 A 348 PRO TYR ASP GLY ILE PRO ALA ARG GLU ILE PRO ASP LEU SEQRES 20 A 348 LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS SEQRES 21 A 348 THR ILE ASP VAL TYR MET ILE MET VAL LYS CYS TRP MET SEQRES 22 A 348 ILE ASP SER GLU CYS ARG PRO ARG PHE ARG GLU LEU VAL SEQRES 23 A 348 SER GLU PHE SER ARG MET ALA ARG ASP PRO GLN ARG PHE SEQRES 24 A 348 VAL VAL ILE GLN ASN GLU ASP LEU GLY PRO ALA SER PRO SEQRES 25 A 348 LEU ASP SER THR PHE TYR ARG SER LEU LEU GLU ASP ASP SEQRES 26 A 348 ASP MET GLY ASP LEU VAL ASP ALA GLU GLU TYR LEU VAL SEQRES 27 A 348 PRO GLN GLN GLY HIS HIS HIS HIS HIS HIS HET W9N A1101 40 HET PEG A1102 7 HET CL A1103 1 HETNAM W9N 1-{(1R,3R,5S)-3-[(3M)-4-METHYL-3-{3-METHYL-4-[(1- HETNAM 2 W9N METHYL-1H-BENZIMIDAZOL-5-YL)OXY]PHENYL}-1H-PYRAZOLO[3, HETNAM 3 W9N 4-D]PYRIMIDIN-1-YL]-8-AZABICYCLO[3.2.1]OCTAN-8- HETNAM 4 W9N YL}PROPAN-1-ONE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM CL CHLORIDE ION FORMUL 2 W9N C31 H33 N7 O2 FORMUL 3 PEG C4 H10 O3 FORMUL 4 CL CL 1- FORMUL 5 HOH *261(H2 O) HELIX 1 AA1 LYS A 716 THR A 718 5 3 HELIX 2 AA2 GLU A 770 MET A 778 1 9 HELIX 3 AA3 CYS A 809 ARG A 818 1 10 HELIX 4 AA4 GLY A 819 LEU A 821 5 3 HELIX 5 AA5 GLY A 822 VAL A 843 1 22 HELIX 6 AA6 ALA A 851 ARG A 853 5 3 HELIX 7 AA7 GLY A 869 ASP A 875 1 7 HELIX 8 AA8 ASP A 877 GLY A 885 5 9 HELIX 9 AA9 PRO A 889 MET A 893 5 5 HELIX 10 AB1 ALA A 894 ARG A 901 1 8 HELIX 11 AB2 THR A 904 THR A 921 1 18 HELIX 12 AB3 PRO A 931 ARG A 933 5 3 HELIX 13 AB4 GLU A 934 LYS A 941 1 8 HELIX 14 AB5 THR A 952 TRP A 963 1 12 HELIX 15 AB6 ASP A 966 ARG A 970 5 5 HELIX 16 AB7 ARG A 972 ARG A 985 1 14 HELIX 17 AB8 ASP A 986 PHE A 990 5 5 HELIX 18 AB9 ASP A 1023 TYR A 1027 5 5 SHEET 1 AA1 6 ARG A 713 ILE A 714 0 SHEET 2 AA1 6 GLY A 791 LEU A 794 1 O ILE A 792 N ARG A 713 SHEET 3 AA1 6 VAL A 798 GLN A 803 -1 O VAL A 801 N GLY A 791 SHEET 4 AA1 6 ILE A 748 LEU A 755 -1 N LYS A 753 O LEU A 800 SHEET 5 AA1 6 GLY A 732 TRP A 739 -1 N GLY A 737 O VAL A 750 SHEET 6 AA1 6 LEU A 720 GLY A 729 -1 N VAL A 723 O LYS A 736 SHEET 1 AA2 2 VAL A 855 SER A 859 0 SHEET 2 AA2 2 HIS A 862 ILE A 865 -1 O LYS A 864 N LEU A 856 LINK SG CYS A 809 C37 W9N A1101 1555 1555 1.76 CRYST1 59.420 59.420 82.484 90.00 90.00 120.00 P 31 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016829 0.009716 0.000000 0.00000 SCALE2 0.000000 0.019433 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012124 0.00000